Termination of Pregnancy: Misoprostol Versus Prostaglandin E2

Authors

  • Imama Tul Bushra Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad Pakistan
  • Faiza Ibrar Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad Pakistan
  • Saima Qamar Department of Obstetrics & Gynaecology, Akhtar Saeed Medical College, Rawalpindi Pakistan
  • Atikka Masud Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad Pakistan
  • Touseef Fatima Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad Pakistan
  • Seema Gul Department of Obstetrics & Gynecology, Watim Medical & Dental College, Islamabad Pakistan

DOI:

https://doi.org/10.51253/pafmj.v73i6.11376

Keywords:

Misoprostol, Prostaglandins, Termination of pregnancy

Abstract

Objective: To compare the efficacy of vaginal Misoprostol and vaginal prostaglandin E2 in termination of pregnancy.

Study Design: Quasi-experimental study.

Place and Duration of Study: Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Islamabad, Pakistan, from
Apr to Oct 2021.

Methodology: After taking informed consent, a total of 80 women between the age of 20-40 years were included in the study
for termination of pregnancy. Molar or ectopic pregnancy, signs of septic abortion, Chronic Liver Disease, and bleeding
disorders were excluded. In group A, a 200µgm tablet of Misoprostol was inserted intravaginal every 6 hours, a total of 4
doses, while in group B patients, a PGE2 3 mg tablet was inserted intravaginal, a total of 4 doses. All patients in both groups
were evaluated after 24 hours, at which efficacy was noted.

Results: The mean age of women in Group-A was 27.18±3.81 years, and in Group-B was 27.18±4.96 years. The mean
gestational age in Group-A was 11.83±3.24 weeks, and in Group-B was 12.20±3.30 weeks. In this study, efficacy (complete
expulsion of the fetus within 24 hours of medication) was seen in 37 (92.50%) women in Group-A (Vaginal Misoprostol) and
29 (72.50%) women in Group-B (Vaginal prostaglandin E2) with a p-value of 0.019.

Conclusion: This study concluded that the efficacy of vaginal Misoprostol is better in termination of pregnancy as compared to
vaginal prostaglandin E2.

Downloads

References

Tanwar M, Zuthsi V. A prospective randomized comparison of

mifepristone with Misoprostol and prostaglandin E2 gel with

Misoprostol for medical termination of pregnancy between 13-

week of gestation. Int J Reprod Contracept Obstet Gynecol

; 9(9): 3654-3660.http://doi.org/10.18203/2320-1770.ijrcog20203835

Devi K, Aftab S, Baloch H, Kumari D, Ayaz S. Role of

Misoprostol 4 hourly versus 6 hourly in medical termination of

pregnancy in 2nd trimester. Professional Med J 2021; 28(11): 1645-

https://doi.org/10.29309/TPMJ/2021.28.11.6285

Shoja S, Yousefi-Sharami SR, Shahgheibi S, Zand-Vakili F, Zare S,

Roshani D, et al. Contrastive analysis of vaginal Misoprostol

and foley catheter in cervical ripening and labor induction. J

Obstet Gynecol Cancer Res 2022; 4(3): 105-110.

https://doi.org/10.30699/jogcr.4.3.105

Nisa S, Razaq F, Nisa S. Comparison of efficacy of Misoprostol 4

hourly with Misoprostol 6 hour for medical termination of

pregnancy in second trimester. Professional Med J 2020; 27(1):

-51. https://doi.org/10.29309/TPMJ/2019.27.01.3169

El-Sayed YA, Behery MM, Abdel Fatah MT. Administration of

Misoprostol sublingual versus vaginal for the termination of

second trimester missed miscarriage. Zagazig Uni Med J 2021;

(4): 631-637. https://doi.org/10.21608/zumj.2019.15870.1420

Serdinšek T, Reljič M, Kovač V. Medical management of

first trimester missed miscarriage: the efficacy and complication

rate. J Obstet Gynaecol 2019; 39(5): 647-651.

https://doi.org/0.1080/01443615.2018.1535577

Majeed F, Al-Ani H. Comparison between different dose

regimens of Misoprostol in termination of early pregnancy.

Tikrit J Pharmac Sci 2019; 14(1): 41-51.

https://doi.org/10.25130/tjphs.2019.14.1.5.41.51

Desouky E, Elsayed AA. Randomized controlled trial between

vaginal Misoprostol alone versus weighted intrauterine foley’s

catheter and vaginal Misoprostol in termination of midtrimester abortion. Evidence Based Women's Health J 2021; 11(2):

-145. https://doi.org/10.21608/EBWHJ.2019.17469.1024

Surrago EJ, Robins J. Midtrimester pregnancy termination by

intravaginal administration of prostaglandin E2. Contraception

; 26: 285-294. https://doi.org/10.1016/0010-7824(82)90076-2.

Carbonell J. Varela L.Velazco A. Early abortion with 800

microgram of Misoprostol by the vaginal route. Contrcep 1999;

: 219-225. https://doi.org/10.1016/s0010-7824(99)00032-3

Nagina FL, Iffat J, Samia S, Tabassum S, Khadija B. Therapeutic

termination of second trimester pregnancies with low dose

Misoprostol . J Coll Physicians Surg Pak 2006; 16: 464-467.

Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH.

Second-trimester pregnancy termination: comparison of three

different methods. J Obstet Gynaecol 2003; 23(4): 407-411.

https://doi.org/0.1080/0144361031000120923

Agrawal NR, Munday A, Sovena J. Misoprostol (PGE1) versus

dinoproston (PGE2) in termination of second trimester pregnancy. J Obstet Gynecol India. 2002; 52(1): 79-81.

Wildshut H, Both MI. Medical methods for midtrimester

termination of pregnancy. Cochrane Database Syst Rev 2011;

(1): 5216. https://doi.org/10.1002/14651858.CD005216.pub2

Bugalho A, Bique C, Almeida L, Bergstrom S. Pregnancy

interruption by vaginal Misoprostol . Gynecol Obstet Invest

; 36(1): 226-229. https://doi.org/10.1159/000292634

Kumar N, Haas DM, Weeks AD. Misoprostol for labour

induction. Best Practice Res Clin Obstet Gynaecol 2021; 77: 53-63.

https://doi.org/0.1016/j.bpobgyn.2021.09.003

Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y, et al.

Mifepristone and Misoprostol versus Misoprostol alone for the

management of missed miscarriage (MifeMiso): a randomised,

double-blind, placebo-controlled trial. Lancet 2020; 396(10253):

-778. https://doi.org/10.1016/S0140-6736(20)31788-8

Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson

MD, Fisher J, et al Miscarriage matters: the epidemiological,

physical, psychological, and economic costs of early pregnancy

loss. Lancet 2021; 397(10285): 1658-1667.

https://doi.org/10.1016/S0140-6736(21)00682-6.

Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002

consecutive cases. Contracept 2004; 69(1): 51-58.

https://doi.org/10.1016/j.contraception.2003.09.006

Gupta N, Mittal S. Is mifepristone needed for second trimester

termination of pregnancy? J Turkish German Gynecol Assoc

; 8(1): 58-66.

Downloads

Published

28-12-2023

Issue

Section

Original Articles

How to Cite

1.
Imama Tul Bushra, Faiza Ibrar, Saima Qamar, Atikka Masud, Touseef Fatima, Seema Gul. Termination of Pregnancy: Misoprostol Versus Prostaglandin E2. Pak Armed Forces Med J [Internet]. 2023 Dec. 28 [cited 2025 Apr. 6];73(6):1800-3. Available from: https://pafmj.org/PAFMJ/article/view/11376